PCYN (Procyon) Marketable Securities: $0.58 Mil (As of Jun. 2024)


PCYN Procyon Corp PCYN
48 GF Score
Price $0.20
View Full Analysis

What is Procyon Marketable Securities?

Procyon PCYN 48 Marketable Securities is $0.58 Mil as of Jun. 2024. GuruFocus rates PCYN with a GF Score™ of 48/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Procyon's Marketable Securities for the quarter that ended in Jun. 2024 was $0.58 Mil.

Procyon's annual Marketable Securities increased from Jun. 2022 ($0.28 Mil) to Jun. 2023 ($0.56 Mil) and increased from Jun. 2023 ($0.56 Mil) to Jun. 2024 ($0.58 Mil).

Procyon  (OTCPK:PCYN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Procyon Marketable Securities Related Terms

Procyon Marketable Securities Historical Data

* Premium members only.

The historical data trend for Procyon's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procyon Marketable Securities Chart

Procyon Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.28 0.28 0.56 0.58

Procyon Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.57 0.57 0.58 0.58
PCYN
48GF Score
Procyon Corp PCYN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Procyon Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.58 Mil mean?
Procyon (PCYN) has a Marketable Securities of $0.58 Mil as of Jun. 2024. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Procyon and its competitors.
Is Procyon's Marketable Securities too high?
Procyon's current Marketable Securities is $0.58 Mil. Overall, Procyon has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Procyon's Marketable Securities compare to KAYS and YCBD?
Procyon's Marketable Securities of $0.58 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Procyon and its competitors. Procyon's current Marketable Securities is $0.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procyon stock overvalued right now?
Procyon (PCYN) has a current Marketable Securities of $0.58 Mil. The current Marketable Securities is $0.58 Mil. Procyon's overall GF Score™ is 48/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Procyon (PCYN), the current Marketable Securities is $0.58 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Procyon Business Description

Address 164 Douglas Road East, Oldsmar, FL, USA, 34677
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
48GF Score

Get the complete analysis for PCYN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price